US Biomax, Inc.
 

Tissue Array and Tissue Microarray from US Biomax

More than 2425 types of tissue array or tissue microarray to choose from.


Tissue Arrays (Microarrays)

Tissue array or tissue microarray from US Biomax includes normal, malignant or metastatic formats. Tissue arrays and Tissue microarrays can be used to validate clinical relevance of potential biological targets in the development of diagnostics, therapeutics and study new protein markers and genes. Tissue arrays (tissue microarrays or tissue-chips) contain protein, RNA, or DNA molecules, thus provides high throughput platforms for the rapid analysis of molecular markers associated with disease diagnosis, prognosis and therapeutics in patients. US Biomax also provides custom tissue array as well as services of immunohistochemistry (IHC) staining and In situ hybridization (ISH) on tissue array or tissue microarray.

Tissue arrays are listed by organ types on the left panel of this page.

Our customers come from a variety of places, including happy customers from NIH, big pharmaceuticals, such as Merck Co., Roche, GSK, Novartis, Genentech, Biogen IDC, etc, big vendors, such as Fisher Scientific and VWR and almost all major universities and research institutions in the United States, not mentioning our strong distribution channels all over the world. We dare to say that tissue arrays from US Biomax have the highest quality in the industry and maintain the most stringent standards on quality controls. US Biomax has been staying at the forefront to maintain the most varieties and quantities of tissue arrays.

Featured US Biomax tissue arrays:

Most viewed tissue microarrays (Hits):

BR1001, Breast cancer tissue array with matched carcinoma metastasis to lymph nodes, 50 cases/100 cores, replaced by BR1004
LC6161, High-density lung cancer array, with stage, grade and normal lung tissue, 322 cases/616 cores
BR6161, High-density breast cancer tissue array, with stage, grade and normal breast tissue, 322 cases/616 cores
ST961, Stomach adenocarcinoma tissue array, including TNM and pathology grade, 48 cases/96 cores
FDA999b, Multiple organ normal tissue array, 47 cases/99 cores, replaced by FDA999c
OR2081, Oral cavity disease spectrum (oral cancer progression) tissue array, 98 cases/208 cores
TP242, Top 4 types of cancer (colon, breast, prostate and lung) 24 core test tissue array, 24 cases/24 cores, replaced by TP242a
PR953, Prostate cancer tissue array with matched normal adjacent tissue and metastatic bones, with TNM, Gleason scores, PSA level and survival data, 40 cases/95 cores, replaced by PR954
BR805, Breast infiltrating lobular carcinoma tissue array, 80 cases/80 cores
FDA901, FDA Standard Frozen Tissue Array, for therapeutic and diagnostic antibody validation for FDA approval, total 30 organs, 3 individual donors per organ, spanning two frozen tissue microarray slides.
BN04011, Normal lung tissue (multi-sites) tissue array, 22 cases/63 cores, replaced by LC725
BR1003, Breast pre-cancerous disease and cancer tissue array (100 cases/101 cores), with clinical stage and pathology grade data
GL803, Brain tumor tissue array of glioblastoma, astrocytoma, ependymoma, oligo astrocytoma, medulloblastoma and oligodendroglioma, 78 cases/80 cores, replaced by GL803a
ME1004a, Malignant melanoma, metastatic malignant melanoma and nevus tissue array, including TNM and clinical stage, 100 cases/100 cores, replaced by ME1004b
MC803, Retinoblastoma, nephroblastoma, neuroblastoma and leukemia tissue array, 40 cases/80 cores, replaced by MC803a
BM482, Multiple myeloma tissue microarray with normal tissue as control, 24 cases/48 cores, replaced by BM483a
BCC38218, Metastatic malignant melanoma tissue array, 50 cases/100 cores
BRC961, Breast cancer array with normal and other non-malignant breast tissues, non-overlapping with BRC962, with AR/ER/PR/Her-2(neu) IHC results, 48 cases/96 cores
BR1503a, Breast cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases/150 cores, with IHC results of Her-2, ER, PR, AR, P53 and Ki67, 75 cases/150 cores, replaced by BR1503b
LY6161, High-density lymphoma and normal lymph node tissue array, 322 cases/616 cores

Newly added tissue microarrays in recent month:

2016-05-16 BL2081a, Bladder cancer high density tissue array, including TNM, clinical stage and pathology grade, 208 cases/208 cores, replacing BL2081
2016-05-16 CO483a, Colon cancer tissue array with normal tissue, including TNM, clinical stage and pathology grade, 48 cases/48 cores, replacing CO483
2016-05-16 RAT901a, Rat multiple organs normal tissue array, 36 cases/90 cores, replacing RAT901
2016-05-16 LN802a, Multiple organ lymph node tissue array, 80 cases/80 cores, replacing LN802
2016-05-16 LV809a, Hepatocellular carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 80 cases/80 cores, replacing LV809
2016-05-09 OV484a, Ovary cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases/48 cores, replacing OV484
2016-05-09 BL806a, Bladder cancer tissue array with adjacent normal tissue, including TNM, clinical stage and pathology grade, 80 cases/80 cores, replacing BL806
2016-05-03 HN803d, Head and neck cancer tissue array with normal tissue, including TNM, clinical stage and pathology grade, 80 cases/80 cores, replacing HN803c
2016-05-03 T141b, Pancreas cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases/24 cores, replacing T141a
2016-04-25 SK801c, Skin squamous cell carcinoma tissue array with adjacent normal skin tissue, including TNM, clinical stage and pathology grade, 80 cases/80 cores, replacing SK801b
2016-04-25 FMC402c, Multiple organ cancer frozen tissue array, with multiple organ normal tissue, including pathology grade, 40 cases/40 cores, replacing FMC402b
2016-04-18 RhFDA1a, FDA multiple organ normal tissue array of rhesus, 7 case/99 cores, replacing RhFDA1
2016-04-11 OS804b, Osteosarcoma tissue array, including TNM, clinical stage and pathology grade, 40 cases/ 80 cores, replacing OS804a
2016-04-11 BR10011a, Triple negative breast cancer tissue array, including TNM, clinical stage and pathology grade, IHC markers (ER, PR, Her-2) results, 100 cases/100 cores, replacing BR10011
2016-04-11 BR1504b, Breast cancer tissue array with adjacent normal breast tissue, including TNM, pathology grade, clinical stage, pathology grade and IHC markers (ER, PR, Her-2) results, 75 cases/ 150 cores, replacing BR1504a
2016-04-09 BR8011a, Breast cancer tissue array with adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 80 cases/80 cores, replacing BR8011
2016-04-05 BS01012c, Stomach adenocarcinoma tissue array, including TNM, clinical stage and pathology grade, 72 cases/ 72 cores, replacing BS01012b
2016-03-31 LC482, Lung cancer and normal lung tissue array, including TNM, clinical stage and pathology grade, 24 cases/48 cores
2016-03-28 CR1101, Cervix cancer tissue array with adjacent normal cervix tissue, including TNM, clinical stage, pathology grade and IHC marker (HPV16/18 and Ki67) results, 110 cases/110 cores
2016-03-28 BC051110b, Colon cancer tissue array with normal colon tissue, including TNM, clinical stage and pathology grade, 120 cases/120 cores, replacing BC051110a